Cargando…

Successful treatment of a COVID-19 patient with thrombotic microangiopathy

Detalles Bibliográficos
Autores principales:	Safak, Seda, Aksoy, Elif, Dirim, Ahmet Burak, Demir, Erol, Garayeva, Nurana, Oto, Ozgur Akin, Artan, Ayse Serra, Yazici, Halil, Besisik, Sevgi, Turkmen, Aydin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929034/ https://www.ncbi.nlm.nih.gov/pubmed/34094522 http://dx.doi.org/10.1093/ckj/sfab024

Ejemplares similares

Minimal change disease following vaccination with CoronaVac
por: Dirim, Ahmet Burak, et al.
Publicado: (2021)

Fatal SARS-CoV-2 infection in a renal transplant recipient
por: Dirim, Ahmet Burak, et al.
Publicado: (2020)

Hydroxychloroquine-Associated Hypoglycemia in Hemodialysis Patients With COVID-19
por: Dirim, Ahmet Burak, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on interest in renal diseases
por: Oto, Ozgur Akin, et al.
Publicado: (2021)

COVID-19 in chronic kidney disease: a retrospective, propensity score-matched cohort study
por: Dirim, Ahmet Burak, et al.
Publicado: (2021)

Outcomes of kidney transplantation in patients with congenital anomalies of the kidney and urinary tract: a propensity-score-matched analysis with case-control design
por: OTO, Özgür Akın, et al.
Publicado: (2023)

Page Kidney: A Rare Cause of Resistant Hypertension Early After Renal Transplantation
por: Dirim, Ahmet Burak, et al.
Publicado: (2021)

Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study
por: Artan, Ayşe Serra, et al.
Publicado: (2023)

COVID-19 in Kidney Transplant Recipients: A Multicenter Experience from the First Two Waves of Pandemic
por: Demir, Erol, et al.
Publicado: (2022)

A Rare Adverse Event after CoronaVac(®)Administration: Neutropenia in a Kidney Transplant Recipient
por: Artan, Ayşe Serra, et al.
Publicado: (2022)

Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients
por: Demir, Erol, et al.
Publicado: (2022)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
por: Baysal, Mehmet, et al.
Publicado: (2018)

Pregnant Woman with Atypical Hemolytic Uremic Syndrome Delivered a Healthy Newborn under Eculizumab Treatment
por: Demir, Erol, et al.
Publicado: (2016)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Thrombotic microangiopathy in renal allografts
por: Radha, S., et al.
Publicado: (2014)

Influenza-associated thrombotic microangiopathies
por: Bitzan, Martin, et al.
Publicado: (2017)

Acyclovir-induced thrombotic microangiopathy
por: Goli, R., et al.
Publicado: (2017)

Cancer-associated thrombotic microangiopathy
por: Govind Babu, K, et al.
Publicado: (2016)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

COVID-19 and thrombotic microangiopathies
por: Tiwari, Nishant R., et al.
Publicado: (2021)

Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021)

Thrombotic microangiopathies: An illustrated review
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2022)

Diagnosis and treatment of thrombotic microangiopathy
por: Thompson, Gemma L., et al.
Publicado: (2022)

Chemotherapy-Associated Thrombotic Microangiopathy
por: Aklilu, Abinet M., et al.
Publicado: (2023)

Thrombotic microangiopathy and associated renal disorders*
por: Barbour, Thomas, et al.
Publicado: (2012)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Thrombotic microangiopathy associated with proteasome inhibitors
por: Lodhi, Ahad, et al.
Publicado: (2015)

Cabozantinib‐induced renal thrombotic microangiopathy
por: La Manna, Gaetano, et al.
Publicado: (2017)

Differential diagnosis of thrombotic microangiopathy in nephrology
por: Sakari Jokiranta, T., et al.
Publicado: (2017)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020)

An Update in Drug-Induced Thrombotic Microangiopathy
por: Chatzikonstantinou, Thomas, et al.
Publicado: (2020)

Thrombotic microangiopathy in oncology – a review
por: Valério, Patrícia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rbv0tqt74cbqastk8amk8dhsur